Literature DB >> 27903018

Intrathecal Baclofen Therapy for the Treatment of Spasticity in Lithuania.

Robertas Kvascevicius1, Ona Lapteva1, Jurate Kesiene2, Alfredas Vaitkus3, Laima Mikulenaite4, Ramunas Raugalas5, Jurate Sipylaite3, Saulius Rocka1, Alvydas Juocevicius2.   

Abstract

Spasticity of cerebral or spinal origin severely impairs an individual's functional ability and quality of life. Intrathecal baclofen (ITB) therapy via an implantable pump is indicated for use in patients unresponsive to oral antispasmodics. ITB therapy improves the daily caring for and relief of painful spasms. In Lithuania, ITB therapy was introduced in clinical practice just recently. We share our experience of spasticity management with the ITB pump system in five patients at Vilnius University Hospital Santariskiu Klinikos. Four patients had spastic tetraplegia associated with cerebral palsy, and one patient developed spastic paraplegia after a spinal epidural abscess. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27903018     DOI: 10.1055/s-0036-1593973

Source DB:  PubMed          Journal:  J Neurol Surg A Cent Eur Neurosurg        ISSN: 2193-6315            Impact factor:   1.268


  1 in total

1.  Intrathecal baclofen in mucopolysaccharidosis type II (Hunter syndrome): case report.

Authors:  František Horn; Michal Petrík; Dana Dúbravová; Jarmila Hornová; Katrína Brennerová; Vladimír Bzduch
Journal:  Childs Nerv Syst       Date:  2018-06-02       Impact factor: 1.475

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.